Stock 4596 KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kubota Pharmaceutical Holdings Co., Ltd.

Equities

4596

JP3266500002

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 06:14:59 30/04/2024 BST 		5-day change 1st Jan Change
69 JPY -1.43% Intraday chart for Kubota Pharmaceutical Holdings Co., Ltd. -1.43% -13.75%
03-22 Kubota Pharmaceutical Adjusts 2023 Financial Results Following Reevaluation MT
03-21 Kubota Pharmaceutical Holdings Co., Ltd. Restates Consolidated and Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 9,942 12,479 11,001 6,833 6,245 4,485
Enterprise Value (EV) 1 -994.8 4,781 5,004 2,617 2,345 1,860
P/E ratio -3.15 x -4.04 x -4.38 x -2.59 x -2.81 x -2.99 x
Yield - - - - - -
Capitalization / Revenue - - 297,314,870 x - 780,680,634 x 115,000,855 x
EV / Revenue - - 135,233,789 x - 293,180,634 x 47,693,163 x
EV / EBITDA 0.31 x -1.47 x -2 x -1.01 x -1.14 x -1.31 x
EV / FCF 0.67 x -2.1 x -3.41 x -1.63 x -1.67 x -1.88 x
FCF Yield 148% -47.7% -29.3% -61.4% -60% -53.1%
Price to Book 0.95 x 1.55 x 1.85 x 1.65 x 1.59 x 1.69 x
Nbr of stocks (in thousands) 40,252 42,303 44,179 45,862 54,308 56,063
Reference price 2 247.0 295.0 249.0 149.0 115.0 80.00
Announcement Date 28/03/19 27/03/20 29/03/21 29/03/22 29/03/23 29/03/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - 37 - 8 39
EBITDA 1 -3,252 -3,243 -2,497 -2,585 -2,053 -1,417
EBIT 1 -3,273 -3,288 -2,542 -2,644 -2,111 -1,504
Operating Margin - - -6,870.27% - -26,387.5% -3,856.41%
Earnings before Tax (EBT) 1 -3,046 -3,104 -2,437 -2,616 -2,015 -1,489
Net income 1 -3,046 -3,065 -2,437 -2,616 -2,015 -1,489
Net margin - - -6,586.49% - -25,187.5% -3,817.95%
EPS 2 -78.42 -73.06 -56.90 -57.46 -40.92 -26.79
Free Cash Flow 1 -1,475 -2,280 -1,468 -1,608 -1,407 -987.6
FCF margin - - -3,966.89% - -17,590.62% -2,532.37%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 27/03/20 29/03/21 29/03/22 29/03/23 29/03/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2022 Q1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3
Net sales 1 0.3554 - - - - 0.0144 0.037 0.1184 0.0924
EBITDA - - - - - - - - -
EBIT 1 -12.08 -12.08 -5.027 -4.984 -8.828 -3.388 -3.288 -5.203 -1.874
Operating Margin -3,400.03% - - - - -23,580.31% -8,898.94% -4,394.18% -2,028.52%
Earnings before Tax (EBT) 1 -11.72 -12.22 -5.088 -5.069 -9.009 -3.41 -3.281 -5.182 -1.867
Net income 1 -11.72 -12.23 -5.088 -5.076 -9.016 -3.41 -3.281 -5.189 -1.86
Net margin -3,297.39% - - - - -23,727.42% -8,878.94% -4,382.42% -2,014.23%
EPS 2 -29.64 -29.86 -12.64 -14.30 -26.02 -9.180 -8.090 -13.48 -5.050
Dividend per Share - - - - - - - - -
Announcement Date 13/08/20 12/08/21 12/11/21 13/05/22 12/08/22 11/11/22 12/05/23 10/08/23 14/11/23
1USD in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 10,937 7,698 5,997 4,216 3,900 2,625
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1,475 -2,280 -1,468 -1,608 -1,407 -988
ROE (net income / shareholders' equity) -25.9% -32.9% -34.6% -51.6% -49.7% -45.1%
ROA (Net income/ Total Assets) -16.6% -20.5% -20.6% -28.7% -28.5% -25.3%
Assets 1 18,379 14,937 11,835 9,121 7,064 5,889
Book Value Per Share 2 261.0 191.0 134.0 90.60 72.30 47.20
Cash Flow per Share 2 64.00 99.10 56.80 86.70 74.10 49.40
Capex 1 22 - 13 8 57 66
Capex / Sales - - 35.14% - 712.5% 169.23%
Announcement Date 28/03/19 27/03/20 29/03/21 29/03/22 29/03/23 29/03/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. Stock Kubota Pharmaceutical Holdings Co., Ltd.
-13.75% 25.15M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 234B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4596 Stock
  4. Financials Kubota Pharmaceutical Holdings Co., Ltd.